← All Tharimmune, INC filings

Tharimmune, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

THAR
Tharimmune, INC
SCHEDULE 13D: Gravitas Capital LP and Executive Chairman Vincent LoPriore Disclose 14.83% Stake in Tharimmune, Inc.
Gravitas Capital LP and its managing member, Vincent S. LoPriore, who also serves as Tharimmune, Inc.'s Executive Chairman, have disclosed a combined beneficial ownership of 14.83% of the company's Common Stock, acquired for investment purposes.